期刊文献+

HPV16L1VLP纯化、鉴定及血凝抑制实验方法的建立

HPV16L1 VLP Purification and Identification and the Establishment of Hemagglutination Inhibition Assay
下载PDF
导出
摘要 摘要通过昆虫细胞-杆状病毒表达系统表达HPV16L1 VLP,纯化鉴定后利用其建立血凝抑制实验,检测HPV16L1单克隆抗体的血凝抑制活性。利用重组杆状病毒感染悬浮培养的昆虫细胞表达HPV16L1蛋白,大量获得VLP;优化扩增蛋白的条件并用SDS-PAGE分析鉴定;经氯化铯密度梯度离心法纯化VLP;利用所得VLP建立血凝抑制试验,鉴定制备的HPV16L1单克隆抗体的血凝抑制活性。优化蛋白表达条件结果显示,当重组杆状病毒感染细胞的MOI=10时目的蛋白表达量最大;按此滴度感染悬浮培养的昆虫细胞,收获、纯化VLP并鉴定其特异性;利用所得VLP建立了血凝抑制实验,鉴定HPV16L1单克隆抗体的血凝抑制效价为1∶16。建立的血凝实验,可用于鉴定和检测HPV16L1相关抗体,为HPV诊断试剂的开发提供实验基础。 Through expression system of insect cells to express human papillomavirus ( HPV ) L1 virus-llke particle (VLP) hemagglutination inhibition assay was established and using it to test its hemagglutination activity of HPV16 L1 monoelonal antibody (MeAb) after purification and identification. Using insect cells suspensively cultured and infected with recombinant baculovirus to express HPV16 L1 proteir, VLP were obtained in great quantity, optimized the conditions of protein amplification analyzed and identified with SDS-PAGE, and then purified the VLP with CsCl gra- dient eentrifugation and established hemagglutination inhibition assay using obtained VLP to identify hemagglutination inhibition activity of the prepared HPV16 L1. The results of the optimized expression of protein showed that when MOI = 10 hours the infected cells with recombinant baeulovirus the expression amount of target protein was the largest. With this titer infected the suspensively cultured insect cells, harvested and purified VLP and identified its specificity. The valence of McAb identified with purified VLPs by hemagglutination inhibition assay was 1: 16. The established hemagglutination assay can be used to identify and test HPV16L1 correlated antibody and provide an assay foundation for HPV diagnosis kits and further development.
出处 《微生物学杂志》 CAS CSCD 2007年第2期29-32,共4页 Journal of Microbiology
基金 黑龙江省攻关课题(GB02C111) 哈尔滨市重点攻关项目(04AA3CS176-1)
关键词 人乳头瘤病毒16型 悬浮培养 病毒样颗粒 HPV16L1单克隆抗体 血凝抑制 human papillomavirus ( HPV ) type 16 suspension culture virus-like particle hemagglutination inhibition
  • 相关文献

参考文献9

  • 1Bosch FX,Manos MM,Munoz N,et al.Prevalence of human papillomavirus in cervical cancer:a worldwide perspective.International biological study on cervical cancer (IBSCC) Study Group[J].J Natl Cancer Inst,1995,87(11):796-802.
  • 2Kirnbauer R,Taub J,Greenstone H,et al.Efficient selfassembly of human papillomavirus type 16 L1 and L1 L2 into virus like particles[J].J Virol,1993,67 (12):6 929-6 936.
  • 3魏兰兰,谷鸿喜,初明,王燕,庄敏,商庆龙,凌虹,张凤民.人乳头瘤病毒16型晚期蛋白L1的表达及病毒样颗粒的装配[J].中华微生物学和免疫学杂志,2004,24(5):383-387. 被引量:4
  • 4魏兰兰,韩立群,任皎,田厚文,骆卫锋,陆振华,谷鸿喜,阮力.人乳头瘤病毒16型结构蛋白在昆虫细胞中的表达[J].中华实验和临床病毒学杂志,2001,15(4):309-313. 被引量:3
  • 5包广宇,谷鸿喜,商庆龙,庄敏.HPV16 L1重组蛋白的纯化及免疫原性的实验研究[J].中华实验和临床病毒学杂志,2005,19(2):164-164. 被引量:1
  • 6Koutsky LA,Ault KA,Wheeler CM,et al.A controlled trial of a human papillomavirus type 16 vaccine[J].N Engl J Med,2002,347(21):1 645-1 651.
  • 7Schiller JT.Papillomaviruslike particle vaccines for cervical cancer[J].Mol Med Today,1999,5 (5):209-215.
  • 8Roden RB,Hubbert NL,Kirnbauer R,et al.Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceoous receptor[J].J Virol,1995,69(8):5 147-5 151.
  • 9Zheng J,Si L,Song J,et al.Enhanced immune response to DNA based HPV16L1 vaccination by costimulatory molecule B72[J].Antiviral Res,2003,59 (1):61-65.

二级参考文献16

  • 1Zhang W,Virology,1998年,243卷,423页
  • 2Zhou J,Virology,1991年,185卷,251页
  • 3Jin X W,J Gen Virol,1989年,70卷,1133页
  • 4Stanley MA.Progress in prophylactic and therapeutic vaccines for human papillomavirus infection.Expert Rev Vaccines,2003,2(3):381-389.
  • 5Sasagawa T,Pushko P,Steers G,et al.Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe.Virology,1995,206(1):126-135.
  • 6Warzecha H,Mason HS,Lane C,et al.Oral immunogenicity of human papillomavirus-like particles expressed in potato.J Virol,2003,77(16):8702-8711.
  • 7Bernard HU,Chan SY,Manos MM,et al.Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification,restriction fragment length polymorphisms,nucleotide sequence,and phylogenetic algorithms.J Infect Dis,199
  • 8Yamada T,Manos MM,Peto J,et al.Human papillomavirus type 16 sequence variation in cervical cancers:a worldwide perspective.J Virol,1997,71(3):2463-2472.
  • 9Sasagawa T,Pushko P,Steers G,et al.Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe.Virology,1995,206(1):126-135.
  • 10Kawana K,Kawana Y,Yoshikawa H,et al.Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies.Vaccine,2001,19(11-12):1496-1502.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部